MANDATORY NOTIFICATION OF TRADE
CFO in Q-Free ASA, Roar Østbø, has today purchased 20 000 shares at an average price of NOK 19.35. New holding of QFR shares after the transaction is 26 000. Trondheim 26th of August 2009
JANUARY 1 – JUNE 30, 2009• Net sales for the period amounted to SEK 34.7 M (27.6) • Profit after tax was SEK 12.3 M (4.2) and earnings per share amounted to SEK 0.36 (0.12) • Operating profit was SEK 16.6 M (4.4) • Cash flow totaled SEK 1.8 M (neg: 15.1) • The collaboration with Nucletron was extended in January with two new products for treatment planning • The first product from the collaboration with TomoTherapy received FDA clearance in January and has been launched • The new VMAT product from the collaboration with Philips was launched in April • A collaboration agreement with Siemens
Read original